Skip to main content
SpringerLink
Log in

Reply to comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyser database

  • Letter to the Editor
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Du L, Li Z, Lan P, Huang H, Cheng W, Xia J (2024) Comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database. Acta Diabetol 59:1443–1451

    Google Scholar 

  2. Rathmann W, Kostev K (2022) Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database. Acta Diabetol 59(11):1443–1451. https://doi.org/10.1007/s00592-022-01943-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Mahmoud F, Mullen A, Sainsbury C et al (2023) Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus. Eur J Clin Invest 53(8):e13997. https://doi.org/10.1111/eci.13997

    Article  CAS  PubMed  Google Scholar 

  4. Hsieh CY, Sung SF (2022) From kidney protection to stroke prevention: the potential role of sodium glucose cotransporter-2 inhibitors. Int J Mol Sci 24(1):351. https://doi.org/10.3390/ijms24010351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kim JS, Lee G, Park KI, Oh SW (2024) Comparative effect of glucose-lowering drugs for type 2 diabetes mellitus on stroke prevention: a systematic review and network meta-analysis. Diabetes Metab J. https://doi.org/10.4093/dmj.2022.0421

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The German Diabetes Center is funded by the German Federal Ministry of Health, the Ministry of Culture and Science of the State of North Rhine-Westphalia, and grants from the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD).

Author information

Authors and Affiliations

  1. Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Auf’m Hennekamp 65, 40225, Düsseldorf, Germany

    Wolfgang Rathmann

  2. German Center for Diabetes Research, Partner Düsseldorf, Munich-Neuherberg, Germany

    Wolfgang Rathmann

  3. IQVIA, Frankfurt, Germany

    Karel Kostev

Authors
  1. Wolfgang Rathmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karel Kostev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wolfgang Rathmann.

Ethics declarations

Conflict of interest

W.R. reports the receipt of consulting fees for attending educational sessions by Novo Nordisk outside of the topic of the current work. K.K. reports no conflict of interest.

Ethical approval and Informed consent

The Disease Analyzer database, used for analysis, contains anonymized electronic patient records. Patient data was analyzed in aggregated form without individual data being available. Patient consent and ethical approval was waived due to national and European legislation.

Additional information

Communicated by Massimo Federici .

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rathmann, W., Kostev, K. Reply to comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyser database. Acta Diabetol (2024). https://doi.org/10.1007/s00592-024-02272-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00592-024-02272-7

Search

Navigation